COMPANY PROFILE

Prevtec microbia

Canadian biotechnology company specialized in the development of vaccines and other technologies that help fight against bacterial diseases in food animals

Montreal, CanadaFounded 2003Food

Valuation $50–100M Last recorded · 2019

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Prevtec microbia

Prevtec Microbia specializes in developing and commercializing innovative microbial solutions aimed at improving animal health and productivity. Operating in the animal health industry, the company primarily serves livestock producers and veterinary professionals. Prevtec Microbia's core product offerings include probiotics and other microbial-based products designed to enhance the gut health of animals, thereby improving their overall well-being and productivity. The company operates on a B2B (business-to-business) model, generating revenue through the sale of its microbial solutions to farms, veterinary clinics, and animal health distributors. By focusing on cutting-edge research and development, Prevtec Microbia aims to address key challenges in animal health, such as disease prevention and growth promotion, while reducing the need for antibiotics. The company is headquartered in Basel, Switzerland, and leverages a global network to distribute its products.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2003
Headquarters: Montreal, Canada
Open positions: None listed
Dealroom signal: 52.4/100
Industry: Food
Sub-industry: AgriTech
Sector: Food, Biotechnology, Vaccines, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITION✓Exit	Aug 2019	$60M	$60M	Elanco	—
DEBTDebt	Jan 2018	$8M	—	Undisclosed	—

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Prevtec microbia website traffic

Latest recorded traffic for Prevtec microbia is 270 monthly website visits.

Latest monthly visits270

Monthly website visitsDec 2018–Jul 2023

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
TRTransAlgaeDevelops an algae-based platform for oral delivery of high value products for Animal Health and Crop Protection	Rehovot, Israel	Operational	10	$2.5M	$10M
BSBotanical SolutionsDeveloping botanical products that are sustainable and cost-effective	Amherst, United States	Operational
PGPacific GeneTechFocuses on developing and commercializing vaccines for the livestock industry through their proprietary Aegis platform	Hong Kong	Operational
MHMazen Animal HealthFocused on developing, delivering, and commercializing novel biological vaccines and therapeutics	Ames, United States	Operational
LMLatch MedicalA new approach to drug and vaccine delivery	Dublin, Ireland	Operational
SASapVaxDeveloping a suite of first-in-class cancer vaccines based on a novel self-adjuvanting peptide platform technology	Cleveland, United States	Operational
ISImmune Targeting SystemsImmune Targeting Systems develops synthetic vaccines for mutating viruses, improving the quality of life for those infected by viruses	Great Barrington, United States	Acquired
SVSolaris VaccinesA biotechnology company that develops therapeutic vaccines for infectious diseases	Fort Collins, United States	Operational